Research Topics
Species | Irit Gil-AdSummaryAffiliation: Tel Aviv University Country: Israel Publications
| Collaborators
|
Detail Information
Publications
Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted miceIrit Gil-Ad
Laboratory of Biological Psychiatry, Felsentein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University and Campus Rabin, Petah Tikva 49100, Israel
Int J Oncol 33:277-86. 2008..Since SSRI therapy is frequently indicated in cancer patients, the use of sertraline in colon cancer patients with co-morbidity of depression seems attractive...
Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growthIrit Gil-Ad
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Rabin Medical Center Beilinson Campus, Petah Tiqva, Israel
Oncol Rep 15:107-12. 2006..resulted in the reduction of lung tumor burden and an increase in mice survival. In conclusion, several phenothiazines, and particularly thioridazine, induced apoptosis of B16 melanoma cells and demonstrated in vivo anti-tumor activity...
Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumorsIrit Gil-Ad
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Campus Rabin, Petah Tiqva 49100, Israel, and Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel
J Mol Neurosci 22:189-98. 2004..Overall, the marked apoptotic effect of phenothiazines in brain-derived cancer cells, and the low sensitivity of primary brain tissue suggest the potential use of selected agents as therapeutic modalities in brain cancer...
Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvementYechiel Levkovitz
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Tel Aviv University, Rabin Campus, Petah Tiqva 49100, Israel
J Mol Neurosci 27:29-42. 2005..The high sensitivity to these drugs of the cancer cell, compared with primary brain tissue, suggests the potential use of these agents in the treatment of brain-derived tumors...
Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expressionMichal Taler
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center and Sackler Faculty of Medicine, Tel Aviv University, Israel
Eur Neuropsychopharmacol 17:774-80. 2007..These findings reveal an immunomodulatory effect of the SSRIs paroxetine and sertraline in human T cells. The clinical implications of our findings merit further investigation...
Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disordersMichal Taler
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center and Sackler Faculty of Medicine, Tel Aviv University, Israel
Int Immunopharmacol 8:526-33. 2008..These findings reveal the immunomodulatory effect of the selected antidepressants. These data suggest a novel use of antidepressants or their derivatives...
The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosisMichal Taler
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Tel Aviv University, Petah Tikva, Israel
Neuroimmunomodulation 18:117-22. 2011..We have previously demonstrated the immunomodulatory activity of some selective serotonin reuptake inhibitors...
In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cellsSivan Tzadok
Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva 49100, Israel
Int J Oncol 37:1043-51. 2010..Thus, it seems that further in vivo studies combining imatinib with psychotropic agents, especially fluoxetine and sertraline, are warranted...
Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitroBen Hayman Amit
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel
Eur Neuropsychopharmacol 19:726-34. 2009..5 microM) markedly enhanced the effects of both vincristine and doxorubicin, suggesting SSRI antidepressants as potential new chemosensitizers in chemotherapeutic regimens, pending further in vivo research...
The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expressionMaya First
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center and Sackler Faculty of Medicine, Tel Aviv University, Beilinson Campus, 49100 Petah Tikva, Israel
J Mol Neurosci 45:246-55. 2011..This study suggests that IGF-1R and ERK may have a role in mediating the neural stress response and the mode of action of FLX. This role seems to be independent of the BDNF alterations...
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinasesYechiel Levkovitz
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Rabin Campus, Petah Tiqva, Israel
Mol Cell Neurosci 36:305-12. 2007..These results implicate selected SSRIs as inhibitors of insulin signaling and as potential inducers of cellular insulin resistance...
The Effects of Reboxetine Treatment on Depression-like Behavior, Brain Neurotrophins, and ERK Expression in Rats Exposed to Chronic Mild StressMaya First
Laboratory of Biological Psychiatry, Felsenstein Medical Research Center and Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, 49100, Israel
J Mol Neurosci 50:88-97. 2013..In conclusion, our study shows that BDNF, its receptor TrkB, and ERK participate in the neurobiological response to chronic stress and in the molecular and cellular activities of REB in the hippocampus...
Relationship between antidepressants and IGF-1 system in the brain: possible role in cognitionNurit Grunbaum-Novak
Lab of Biological Psychiatry, Felsenstein Medical Research Center and Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel
Eur Neuropsychopharmacol 18:431-8. 2008..FLX did not affect cognitive performance. Thus, repeated FLX treatment leads to upregulation of IGF-1 system is FC. It is possible that FLX affect FC neuroplasticity through activation of the IGF-1 system...
A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effectsAbraham Nudelman
Department of Chemistry, Bar Ilan University, Ramat Gan, Israel
J Med Chem 51:2858-62. 2008..Thus, 3 (BL-1020) constitutes a prototype of novel antipsychotics possessing GABAergic activity. A phase II study is in progress...
Immunomodulatory effect of sertraline in a rat model of rheumatoid arthritisEhud Baharav
Laboratory of Joint Pathophysiology and Inflammation, Department of Medicine C, Rabin Medical Center, Petach Tikva, Israel
Neuroimmunomodulation 19:309-18. 2012..SSRIs are the preferred treatment for major depressive disorder (MDD). A high rate of MDD is observed in rheumatoid arthritis (RA) patients. The aim of this study was to evaluate immunological effects of SSRIs in a rat model of RA...
Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile ratsRina Eshet
Laboratory of Endocrinology and Diabetes, Felsenstein Medical Research Center, Petah Tikva, Israel
J Mol Neurosci 22:179-88. 2004..Because IGF-I is a potent neurotrophic agent, this effect may have important implications for states of neurodegenerative diseases...
Gamma-aminobutyric acid amides of nortriptyline and fluoxetine display improved pain suppressing activityAda Rephaeli
Laboratory of Pharmacology and Experimental Oncology, Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
J Med Chem 52:3010-7. 2009..Amide 1 was most efficacious in lowering cytokine secretion, edema and hyperalgesia induced by formalin and lambda-carrageenan, respectively. Thus, 1 is a promising candidate for the treatment of pain...
Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine additionMichael Poyurovsky
Research Unit, Tirat Carmel Mental Health Center, Israel
Am J Psychiatry 159:1058-60. 2002..The two groups demonstrated similar and substantial gradual weight gains. CONCLUSIONS: These results suggest that fluoxetine coadministration is clinically ineffective and cannot attenuate olanzapine-induced weight gain...
Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled studyMichael Poyurovsky
Research Unit, Tirat Carmel Mental Health Center, P O Box 9, Tirat Carmel, 30200, Israel
Psychopharmacology (Berl) 192:441-8. 2007..In the present study, we sought to replicate our preliminary findings, which indicated that coadministration of the selective norepinephrine reuptake inhibitor reboxetine attenuates olanzapine-induced weight gain...
The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot studyMichael Poyurovsky
Research Unit, Tirat Carmel Mental Health Center, 9 Eshkol Street, 30200 Tirat Carmel, Israel
Eur Neuropsychopharmacol 14:332-6. 2004..In conclusion, famotidine (40 mg/day for 6 weeks) is not effective in preventing/attenuating weight gain in olanzapine-treated first-episode schizophrenia patients...
